Goldman Sachs analysts gave ‘buy' ratings to five of the 10 publicly traded health insurers it now covers. Just one got a ‘sell' rating.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}